Advanced Solid Malignancies Completed Phase 1 Trials for AZD-5363 (DB12218)

Also known as: Advanced Solid Malignancy

IndicationStatusPhase
DBCOND0034803 (Advanced Solid Malignancies)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01895946Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and TolerabilityTreatment
NCT01353781Open Label Phase 1 Study in Japan for Patient With Advanced Solid MalignanciesTreatment